99 related articles for article (PubMed ID: 1806940)
1. A rational search for the separation of psychoactivity and analgesia in cannabinoids.
Reggio PH; McGaughey GB; Odear DF; Seltzman HH; Compton DR; Martin BR
Pharmacol Biochem Behav; 1991 Nov; 40(3):479-86. PubMed ID: 1806940
[TBL] [Abstract][Full Text] [Related]
2. The importance of the orientation of the C9 substituent to cannabinoid activity.
Reggio PH; Greer KV; Cox SM
J Med Chem; 1989 Jul; 32(7):1630-5. PubMed ID: 2738895
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological properties of 11-hydroxy-3-(1',1'-dimethylheptyl)hexahydrocannabinol: a high-affinity cannabinoid agonist.
Yan G; Yin D; Khanolkar AD; Compton DR; Martin BR; Makriyannis A
J Med Chem; 1994 Aug; 37(16):2619-22. PubMed ID: 8057304
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the role of the phenolic hydroxyl in cannabinoid activity.
Reggio PH; Seltzman HH; Compton DR; Prescott WR; Martin BR
Mol Pharmacol; 1990 Dec; 38(6):854-62. PubMed ID: 2174506
[TBL] [Abstract][Full Text] [Related]
5. Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain.
Tripathi HL; Vocci FJ; Brase DA; Dewey WL
Alcohol Drug Res; 1987; 7(5-6):525-32. PubMed ID: 3620017
[TBL] [Abstract][Full Text] [Related]
6. Importance of the C-1 substituent in classical cannabinoids to CB2 receptor selectivity: synthesis and characterization of a series of O,2-propano-delta 8-tetrahydrocannabinol analogs.
Reggio PH; Wang T; Brown AE; Fleming DN; Seltzman HH; Griffin G; Pertwee RG; Compton DR; Abood ME; Martin BR
J Med Chem; 1997 Sep; 40(20):3312-8. PubMed ID: 9379452
[TBL] [Abstract][Full Text] [Related]
7. The pharmacological activity of the fatty acid conjugate 11-palmitoyloxy-delta 9-tetrahydrocannabinol.
Haggerty GC; Deskin R; Kurtz PJ; Fentiman AF; Leighty EG
Toxicol Appl Pharmacol; 1986 Jul; 84(3):599-606. PubMed ID: 3726879
[TBL] [Abstract][Full Text] [Related]
8. Evidence of 11-Hydroxy-hexahydrocannabinol and 11-Nor-9-carboxy-hexahydrocannabinol as Novel Human Metabolites of Δ
Falck Jørgensen C; Schou Rasmussen B; Linnet K; Thomsen R
Metabolites; 2023 Nov; 13(12):. PubMed ID: 38132851
[TBL] [Abstract][Full Text] [Related]
9. Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs.
Little PJ; Compton DR; Mechoulam R; Martin BR
Pharmacol Biochem Behav; 1989 Mar; 32(3):661-6. PubMed ID: 2544901
[TBL] [Abstract][Full Text] [Related]
10. Common cannabimimetic pharmacophoric requirements between aminoalkyl indoles and classical cannabinoids.
Xie XQ; Eissenstat M; Makriyannis A
Life Sci; 1995; 56(23-24):1963-70. PubMed ID: 7776820
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a region of steric interference at the cannabinoid receptor using the active analog approach.
Reggio PH; Panu AM; Miles S
J Med Chem; 1993 Jun; 36(12):1761-71. PubMed ID: 8510104
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological evaluation of halogenated delta 8-THC analogs.
Charalambous A; Lin S; Marciniak G; Banijamali A; Friend FL; Compton DR; Martin BR; Makriyannis A
Pharmacol Biochem Behav; 1991 Nov; 40(3):509-12. PubMed ID: 1666915
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological evaluation of water soluble cannabinoids and related analogs.
Compton DR; Martin BR
Life Sci; 1990; 46(22):1575-85. PubMed ID: 2352451
[TBL] [Abstract][Full Text] [Related]
14. Novel 1',1'-chain substituted hexahydrocannabinols: 9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (AM2389) a highly potent cannabinoid receptor 1 (CB1) agonist.
Nikas SP; Alapafuja SO; Papanastasiou I; Paronis CA; Shukla VG; Papahatjis DP; Bowman AL; Halikhedkar A; Han X; Makriyannis A
J Med Chem; 2010 Oct; 53(19):6996-7010. PubMed ID: 20925434
[TBL] [Abstract][Full Text] [Related]
15. Novel C-Ring-Hydroxy-Substituted Controlled Deactivation Cannabinergic Analogues.
Kulkarni S; Nikas SP; Sharma R; Jiang S; Paronis CA; Leonard MZ; Zhang B; Honrao C; Mallipeddi S; Raghav JG; Benchama O; Järbe TU; Bergman J; Makriyannis A
J Med Chem; 2016 Jul; 59(14):6903-19. PubMed ID: 27367336
[TBL] [Abstract][Full Text] [Related]
16. A potent antinociceptive cannabinoid which lacks opiate substitution properties in monkeys.
Martin BR; Dewey WL; Aceto MD; Adams MD; Earnhardt JT; Carney JM
Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):187-90. PubMed ID: 402685
[TBL] [Abstract][Full Text] [Related]
17. Stereospecific elimination of deuterium as a method for determining the stereochemistry of a number of metabolites of the tetrahydrocannabinols.
Harvey DJ
Biomed Mass Spectrom; 1980 Jan; 7(1):28-34. PubMed ID: 6249411
[TBL] [Abstract][Full Text] [Related]
18. 9-Nor-9-hydroxyhexahydrocannabinols. Synthesis, Some behavioral and analgesic properties, and comparison with the tetrahydrocannabinols.
Wilson RS; May EL
J Med Chem; 1976 Sep; 19(9):1165-7. PubMed ID: 978681
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity studies of morphine fragments. I. 4-alkyl-4-(m-hydroxy-phenyl)-piperidines.
Loew GH; Lawson JA; Uyeno ET; Toll L; Frenking G; Polgar W; Ma LY; Camerman N; Camerman A
Mol Pharmacol; 1988 Sep; 34(3):363-76. PubMed ID: 2843751
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological potency of R- and S-3'-hydroxy-delta 9-tetrahydrocannabinol: additional structural requirement for cannabinoid activity.
Martin BR; Kallman MJ; Kaempf GF; Harris LS; Dewey WL; Razdan RK
Pharmacol Biochem Behav; 1984 Jul; 21(1):61-5. PubMed ID: 6087379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
